What Is Urolithin A? Benefits, Uses, and Scientific Insights

Urolithin A (UA) is a naturally occurring postbiotic produced when gut microbiota metabolize dietary polyphenols—such as ellagic acid and ellagitannins. It cannot be obtained directly from food sources but relies instead on the transformative activity of intestinal microorganisms for its generation. Characterized by a unique α-benzocoumarin structure, UA possesses the attributes of a small molecule: high lipophilicity and ease of absorption, enabling it to traverse various physiological barriers to exert its effects. In recent years, it has emerged as a focal point of scientific research in fields such as anti-aging, mitochondrial health, and muscle protection. Its efficacy and practical value have been progressively substantiated by extensive clinical and basic research, thereby establishing a consensus within the industry that is grounded in both scientific rigor and practical utility.

What is Urolithin A?

Basic Definition: Urolithin A is a naturally occurring active metabolite. Its chemical name is 3,8-dihydroxy-6H-benzo[c]chromen-6-one; it has the molecular formula C₁₃H₈O₄ and the CAS number 1143-70-0. It appears as a white to off-white powder and is readily soluble in DMSO. It is typically stored at temperatures between 2°C and 8°C to preserve its biological activity. Its purity can be verified using High-Performance Liquid Chromatography (HPLC); standard-grade raw materials typically achieve a purity of over 97%, while premium-grade products can exceed 99% purity.

Key Characteristics: It possesses a high degree of natural safety; standardized toxicological assessments in both human subjects and animal models have confirmed that it presents minimal side effects, and it has received recognition from the U.S. FDA. Due to its low molecular weight and strong lipophilicity, it is easily absorbed by the human body and is capable of crossing the blood-brain barrier to act directly upon the central nervous system. Its biological activity is contingent upon conversion by gut microbiota; research indicates that only 30% to 40% of the human population possesses the specific gut microbiota capable of efficiently converting ellagic acid into Urolithin A. Furthermore, this conversion capacity tends to diminish with age—a primary reason why oral supplementation has become the predominant method of intake.

Natural Sources and Conversion Mechanism: The precursors to Urolithin A—specifically ellagic acid and ellagitannins—are widely found in various fruits, vegetables, and nuts, including pomegranates, strawberries, raspberries, walnuts, and almonds, with pomegranates being a particularly rich source. Upon the ingestion of these precursor-rich foods, specific strains of gut microbiota within the human intestine break down and metabolize these compounds, ultimately yielding Urolithin A. Variations in the composition of an individual's gut microbiota directly determine the quantity of Urolithin A produced within their body; this factor serves as the key determinant explaining why different individuals may experience markedly different physiological effects even after consuming the exact same foods. - Production and Specifications: Current mainstream production methods utilize either biological fermentation or chemical synthesis processes. Notably, our proprietary, independently developed fermentation process enables high-purity, large-scale supply while ensuring both environmental sustainability and traceability. Standard raw material packaging specifications include 1 kg bags and 25 kg cardboard drums. The product has a shelf life of approximately two years and requires storage in a sealed container in a cool, dark place to prevent loss of activity. For finished products, the inclusion dosage of Urolithin A must be adjusted according to the specific application scenario; for oral dietary supplements, the standard daily dosage typically ranges from 500 to 1,000 mg.

The Core Benefits of Urolithin A

(I) Activating Mitophagy and Delaying Cellular Senescence

This constitutes Urolithin A’s most fundamental and extensively researched benefit—the primary reason it has been hailed as a "cutting-edge technology for mitochondrial regeneration and anti-aging." Scientific studies have confirmed that Urolithin A operates by activating the PTEN-induced putative kinase 1 (PINK1)/Parkin signaling pathway to selectively clear damaged and dysfunctional mitochondria within cells (a process known as mitophagy). Simultaneously, it promotes the generation of new, healthy mitochondria, restores mitochondrial energy metabolic function, and reduces the accumulation of reactive oxygen species (ROS), thereby delaying the cellular aging process at a molecular level. A 2021 study published in the journal *Nature Metabolism* demonstrated that following Urolithin A supplementation, elderly individuals exhibited significantly improved mitochondrial function in their muscle cells and a marked reduction in aging-related cellular damage. Furthermore, by activating the SIRT1-NAMPT pathway, Urolithin A enhances the endogenous synthesis of NAD+ within the body; in mouse models, this effect resulted in an approximately 50% increase in NAD+ levels—an efficacy equivalent to that of a five-fold dose of NR—thereby further bolstering cellular metabolism and anti-aging capabilities.

(II) Protecting Muscle Function and Mitigating Muscle Loss

Muscle aging is a hallmark feature of the aging process, closely linked to declining mitochondrial function, chronic inflammation, and disruptions in protein metabolism. Urolithin A addresses these issues by employing multi-target mechanisms to synergistically improve muscle health. Research indicates that Urolithin A enhances the activity of the AMPK signaling pathway in skeletal muscle, boosts the function of mitochondrial respiratory chain complexes, and promotes fatty acid oxidation and ATP production, thereby improving muscle endurance and peak oxygen uptake. Concurrently, it inhibits inflammatory signaling pathways—such as NF-κB and Akt/MAPK—downregulates pro-inflammatory factors (e.g., TNF-α and IL-1β), and upregulates anti-inflammatory factors (e.g., IL-10 and TGF-β1), thereby mitigating inflammation-induced muscle damage and delaying muscle atrophy. Animal studies have demonstrated that Urolithin A supplementation enhances the grip strength of sleep-deprived mice by 55.6% and extends their time to fatigue by approximately 100%—effects that surpass those of caffeine. Clinical studies have further confirmed that Urolithin A supplementation leads to significant improvements in muscle strength and physical performance in older adults, offering a novel strategy for addressing age-related muscle loss.

(III) Regulating Gut Health and Circadian Rhythms

Urolithin A shares a mutually beneficial relationship with the gut microbiota: as a metabolic product of the gut flora, it reciprocally regulates the balance of the gut microecosystem. It inhibits the growth of harmful bacteria, promotes the repair of the intestinal mucosa, and reduces intestinal inflammation, thereby providing some relief for gastrointestinal discomforts such as diarrhea and bloating. Furthermore, recent research has revealed that Urolithin A can ameliorate circadian rhythm disruptions by modulating the "gut-systemic rhythm axis." The primary mechanism involves restoring the normal rhythm of clock genes within intestinal cells and mitigating rhythm dysregulation caused by inflammatory factors. Simultaneously, by stabilizing SIRT1 activity and promoting PER2 degradation, it enhances the expression of *Bmal1*—a key clock gene—in senescent cells. This action subsequently modulates the central clock system located in the suprachiasmatic nucleus of the hypothalamus, thereby improving sleep quality and alleviating the fatigue and low energy levels associated with sleep deprivation.

(IV) Immune Remodeling, Anti-inflammatory, and Antioxidant Effects

A clinical study published in the journal *Nature Aging* in 2025 confirmed that Urolithin A possesses significant immunomodulatory properties. Following four weeks of daily supplementation with 1,000 mg of Urolithin A, healthy middle-aged adults exhibited a significant expansion of peripheral CD8+ T cells characterized by a "naïve-like" phenotype and reduced terminal exhaustion. Concurrently, the fatty acid oxidation capacity of these CD8+ T cells increased by 14.72 percentage points. Additionally, there was an increase in the populations of NK cells and non-classical monocytes—cell types that play pivotal roles in combating infections and clearing abnormal cells—thereby effectively mitigating age-related immune decline. Furthermore, Urolithin A exhibits potent antioxidant activity; it enhances the activity of antioxidant enzymes—such as catalase, superoxide dismutase, and glutathione peroxidase—inhibits the generation of reactive oxygen species, and mitigates cellular damage caused by oxidative stress. Concurrently, its anti-inflammatory properties extend systemically, offering a degree of relief for conditions involving joint inflammation and neuroinflammation.

(V) Other Potential Benefits (Currently Under Scientific Investigation)

The scope of research into Urolithin A is currently expanding rapidly, with numerous clinical and basic science studies revealing a growing range of potential applications. In the realm of adjunctive cancer therapy, Urolithin A may inhibit the initiation and progression of various malignancies—including colon, prostate, and bladder cancers—by downregulating oncogenes such as mTOR and K-Ras while upregulating tumor suppressor genes like p53 and EGFR; the U.S. National Cancer Institute is currently conducting a Phase II clinical trial to investigate its efficacy as an adjunctive treatment for patients with prostate cancer. Regarding reproductive health, Urolithin A may help preserve ovarian reserve and mitigate chemotherapy-induced ovarian damage by blocking the PI3K/Akt signaling pathway to maintain follicular dormancy, thereby offering new avenues for improving fertility. Finally, in the field of neuroprotection, its ability to cross the blood-brain barrier suggests a potential protective role against neurodegenerative disorders such as Alzheimer's disease, with ongoing research continuing to elucidate the underlying mechanisms.

The primary uses of Urolithin A​​​​​​​​​​​​​​

Application Areas	Representative Products	Key Application Points and Scientific Basis
Dietary Supplements	High-Purity Urolithin A Capsules/Tablets, Comprehensive Anti-Aging Formulas (Blended with PQQ, CoQ10, and NMN), Sports Nutrition Supplements, Sleep Regulation Formulas	Formulated with raw materials of over 97% high purity, this product offers high oral absorption efficiency and caters to the diverse needs of various demographics: for middle-aged and elderly individuals, it focuses on mitochondrial anti-aging, muscle protection, and immune support; for athletes and active individuals, it targets the enhancement of muscle endurance and post-exercise recovery; and for those experiencing poor sleep, it serves to regulate circadian rhythms and improve sleep quality. Common combination regimens include "Urolithin A + PQQ" to reinforce mitochondrial protection, and "Urolithin A + PS + DHA" to support brain health—both of which are backed by relevant scientific data demonstrating their synergistic effects.
Functional Skincare	Anti-aging serums, firming creams, and skin barrier repair products.	Enriched with high-purity Urolithin A, this product harnesses its antioxidant and anti-inflammatory properties to mitigate oxidative skin damage, safeguard mitochondrial function within skin cells, enhance the skin barrier, boost skin elasticity, and diminish the appearance of wrinkles. Clinical studies have demonstrated that healthy women aged 40 to 60 who took a daily oral supplement of 500 mg of Urolithin A for 56 consecutive days experienced significant improvements in skin elasticity and firmness, a reduction in wrinkle area, and a marked improvement in transepidermal water loss. This formulation is suitable for all skin types, including sensitive skin.
Pharmaceutical R&D	Candidate Drugs for the Adjunctive Treatment of Neurodegenerative Diseases; Adjunctive Therapies for Muscle Atrophy; Adjunctive Preparations for Prostate Cancer; Ovarian Protection-Related Drugs	Based on high-purity raw materials, clinical studies are being conducted with a focus on mechanisms such as mitochondrial function restoration, inflammation suppression, and immune modulation. Currently, clinical trials targeting prostate cancer and neurodegenerative diseases are underway; in the future, this holds promise as a novel option for the adjunctive treatment of these conditions. Furthermore, it can serve as a substitute for certain antioxidant components in the development of therapeutics for ischemia-reperfusion injury.
Sports Nutrition and Pet Health	Athletic Endurance Supplements, Pet Anti-Aging Health Products, Aquaculture Feed Additives	In the field of sports nutrition, when combined with compounds such as L-carnitine and arginine, it enhances athletes' muscular endurance and athletic performance while accelerating post-exercise recovery. In the realm of pet health, it is utilized for anti-aging and joint protection, improving muscle function and vitality in senior pets. In aquaculture, it serves as a feed additive to safeguard the cellular health of farmed animals and boost production performance, while also acting as a color-retention agent to extend product shelf life.

Scientific Insights and Research Progress on Urolithin A​​​​​​​​​​​​​​

(I) Core Scientific Consensus

Conversion Specificity: The *in vivo* production of Urolithin A is dependent on the gut microbiota and exhibits significant individual variability; only 30–40% of the population can efficiently convert its precursor substances. Consequently, direct oral supplementation represents the most reliable method to ensure its efficacy. This conclusion has been substantiated by numerous human studies and stands as one of the industry's core tenets today.

Mechanistic Clarity: Its core mechanism of action involves activating mitophagy—the selective clearance of damaged mitochondria—while simultaneously promoting the generation of healthy mitochondria. Furthermore, it modulates anti-aging pathways such as SIRT1 and AMPK, thereby enhancing the endogenous synthesis of NAD+. This mechanism has been dually validated through both basic laboratory experiments and clinical studies, constituting its primary competitive advantage and distinguishing it from other anti-aging ingredients.

Reliable Safety Profile: Multiple toxicological studies and clinical trials have demonstrated that Urolithin A presents no significant toxic side effects and exhibits excellent oral tolerability, making it suitable for long-term supplementation. The U.S. FDA has issued a positive safety assessment regarding Urolithin A, while the EU has recognized its utility as a natural active ingredient, thereby laying a solid foundation for its large-scale commercial application.

(II) Latest Research Advancements (2024–2026)

Immunomodulation:** In 2025, a clinical study conducted by the University Hospital Frankfurt (Germany) confirmed that short-term supplementation with Urolithin A can induce metabolic reprogramming in immune cells. This process enhances the activity of CD8+ T cells and NK cells, thereby ameliorating age-related immune decline and providing a new scientific basis for the development of immune-support products.

Sleep and Circadian Rhythm Regulation: Multiple studies conducted between 2024 and 2025 indicate that Urolithin A can regulate the gut-brain circadian axis, restore the rhythmicity of intestinal clock genes, alleviate circadian rhythm disruptions, and mitigate fatigue resulting from sleep deprivation. Ongoing clinical trials (e.g., NCT06990256) are currently further validating its efficacy in improving human sleep quality.

Reproductive Health: A study published in the journal *Biology* in 2025 demonstrated that Urolithin A can protect ovarian reserve, delay follicular depletion, and counteract ovarian damage induced by chemotherapy. This discovery opens up new avenues for research into the protection of female reproductive health, and related R&D efforts regarding its application are currently underway. - **Dosage Form Optimization:** To enhance absorption efficiency, the industry is currently advancing the application of formulation technologies—such as nanoliposomes and cyclodextrin encapsulation—while simultaneously developing a diverse range of dosage forms (including gummies, powders, stick packs, and drops). These efforts aim to cater to the consumption habits of various demographics, driving the evolution of products toward greater convenience and a "snack-like" format.

(III) Existing Research Controversies and Future Directions

Current research on Urolithin A still presents several areas requiring further refinement: First, data regarding the safety of long-term supplementation remains insufficient; existing studies largely focus on short-term durations (4–12 weeks), whereas the effects of long-term supplementation (exceeding one year) on the human body require further validation. Second, the optimal dosage has not yet been fully established; appropriate dosages vary across different populations (e.g., the elderly, athletes, and pregnant women), necessitating more large-scale clinical studies to define them precisely. Third, the mechanistic link between gut microbiota and the conversion of Urolithin A requires deeper exploration; future research holds the potential to enhance the body's endogenous production capacity for Urolithin A by modulating gut microbiota, thereby achieving a dual-pronged approach involving both "endogenous and exogenous" supplementation.

Future research efforts will focus primarily on three key directions: First, expanding the scope of clinical studies to validate the practical efficacy of Urolithin A in fields such as neurodegenerative diseases, adjunctive cancer therapies, and reproductive health. Second, optimizing manufacturing processes and reducing raw material costs to facilitate the widespread accessibility and democratization of these products. Third, delving deeper into the mechanisms of its synergistic interactions with other anti-aging ingredients to develop more targeted formulations, thereby maximizing their therapeutic potential and efficacy ceiling.

Important Considerations

Although Urolithin A boasts a high safety profile, it is essential to adhere to principles of responsible supplementation. Excessive intake may increase the metabolic burden on the gut; specific dosages should be determined based on product instructions or professional medical advice. For oral supplements, the standard daily dosage typically does not exceed 1000 mg.

Raw materials must be stored under strictly controlled conditions: sealed, in a cool place (2–8°C), and protected from light. Exposure to high temperatures or humid environments can lead to a loss of bioactivity and compromise product efficacy. Different purity levels of Urolithin A are suited for different applications; high-end skincare products and pharmaceutical R&D projects, in particular, require raw materials with a purity level exceeding 99%.

Pregnant women, breastfeeding mothers, children, and individuals currently taking anticoagulant medications or immunosuppressants should consult a physician or nutritionist before using products containing Urolithin A to avoid potential drug interactions.

Clinical research regarding Urolithin A within the pharmaceutical sector is currently ongoing. Its long-term safety and specific therapeutic efficacy still require further validation through additional clinical data; therefore, it should not be used as a substitute for prescribed medications in the treatment of specific diseases.

When purchasing Urolithin A raw materials or related products, priority should be given to key indicators such as purity, manufacturing processes, and laboratory test reports. It is advisable to select products from reputable manufacturers that hold relevant regulatory certifications and possess clear scientific backing, thereby avoiding the use of substandard raw materials that could compromise the quality of the final product.

In summary, as a natural postbiotic, Urolithin A has achieved widespread application in fields such as dietary supplementation, functional skincare, and sports nutrition—thanks to its well-defined mechanism for activating mitochondrial autophagy and its multifaceted health benefits. Furthermore, as scientific research continues to advance, the scope of its potential applications is constantly expanding. Although certain research findings remain subject to ongoing debate, the continuous accumulation of clinical data and the optimization of manufacturing technologies position Urolithin A to emerge as a pivotal ingredient in areas such as healthy aging, immune support, and muscle preservation, offering novel solutions for human health.

Partner with Gold Herb for Premium ​​​​​​​Urolithin A Supply

You can trust Gold Herb to give you good Urolithin A  because they use advanced extraction methods and strict quality control checks. There are documents from the FDA, ISO9001, HACCP, Halal, and Kosher that back up these extracts. We've been in business for over three years and have helped over 200 people in 30 different countries. We always have more than a ton of things on hand so that we can ship your order right away, within 24 hours of getting it. We will always be able to come up with new ideas and make better goods because we work together with Academician Li Xiaokun's study team. Email info@newgoldherb.com to tell us about your specific needs, get samples, or find out more about our full customization services, which will save you a lot of money on your recipe needs.